Dachaigh › Ailse metastatach › Connecticut › New Haven
Sgrùdaidhean clionaigeach Ailse metastatach ann an New Haven, CT
Tha 23 sgrùdaidhean airson Ailse metastatach a’ lorg phàirtichean aig làraichean ann agus timcheall air New Haven (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Yale Cancer Center, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
A’ fastadhÌre 1
- Yale - New Haven Hospital, New Haven
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
A’ fastadhÌre 1/2
- Yale Cancer Center-Yale University, New Haven
A Study of ASP3082 in Adults With Advanced Solid Tumors
A’ fastadhÌre 1
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
A’ fastadhÌre 3
- Research Site, New Haven
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A’ fastadhÌre 3
- Yale-New Haven Hospital, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A’ fastadhÌre 3
- Yale University School of Medicine, New Haven
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
A’ fastadhÌre 2
- Yale University, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A’ fastadhÌre 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Yale University School of Medicine, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
A’ fastadhÌre 1/2
- Crinetics Study Site, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
A’ fastadhÌre 1/2
- Yale University, New Haven
A Study of ASP1002 in Adults for Treatment of Solid Tumors
A’ fastadhÌre 1
- Yale University Cancer Center, New Haven
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #4, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A’ fastadhÌre 1
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
A’ fastadhÌre 1
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
A’ fastadhÌre 1/2
- Yale School of Medicine, North Haven · 7 mìle air falbh
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
A’ fastadhÌre 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
A’ fastadhÌre 3
- Yale Cancer Center, New Haven
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
A’ fastadhÌre 1
- Yale Cancer Center, New Haven
Sgrùdaidhean Ailse metastatach ann am bailtean eile
- Houston, TX104 sgrùdaidhean
- New York City, NY93 sgrùdaidhean
- Nashville, TN70 sgrùdaidhean
- Boston, MA63 sgrùdaidhean
- Los Angeles, CA57 sgrùdaidhean
- St. Louis, MO54 sgrùdaidhean
- Arlington, VA53 sgrùdaidhean
- Philadelphia, PA46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Antonio, TX44 sgrùdaidhean
- Washington, DC43 sgrùdaidhean
- Dallas, TX42 sgrùdaidhean
Sgrùdaidhean eile ann an New Haven
- Aillse Sgamhain Neo-chealla-beag41 sgrùdaidhean
- Aillse a' bhroilleach38 sgrùdaidhean
- Aillse (gach seòrsa)33 sgrùdaidhean
- Ailseachadh nan Sgamhan22 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil22 sgrùdaidhean
- Cancer Ovarian21 sgrùdaidhean
- Aillse colorectal20 sgrùdaidhean
- Aillse Prostata20 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Disorder of Alcohol Use (AUD)17 sgrùdaidhean
- Overdose Opioid17 sgrùdaidhean
- Cancer Pancreatic16 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.